TY  - JOUR

T1  - SB16 versus reference denosumab in postmenopausal women with osteoporosis: 18-month outcomes of a phase III randomized clinical trial

JO  - Bone

UR  - https://eprints.whiterose.ac.uk/id/eprint/232830

PY  - 2024/12/12

AU  - Chung Y-S

AU  - Langdahl B

AU  - Plebanski R

AU  - Czerwinski E

AU  - Dokoupilova E

AU  - Supronik J

AU  - Rosa J

AU  - Mydlak A

AU  - Sapula R

AU  - Rowińska-Osuch A

AU  - Baek K-H et al

ED  - 

DO  - DOI: 10.1016/j.bone.2024.117371

PB  - Elsevier BV

VL  - 192

Y2  - 2025/10/25

ER  -